ArticleInternational journal of molecular sciences2022

Ketoconazole Reverses Imatinib Resistance in Human Chronic Myelogenous Leukemia K562 Cells.

Omar Prado-Carrillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.